These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 19859715

  • 1. One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs.
    Giardina A, Ferrante A, Ciccia F, Vadalà M, Giardina E, Triolo G.
    Rheumatol Int; 2011 Jan; 31(1):33-7. PubMed ID: 19859715
    [Abstract] [Full Text] [Related]

  • 2. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M, Pirraglia MP, Paroli MP, Priori R, Conti F, Pivetti-Pezzi P.
    Jpn J Ophthalmol; 2007 Jan; 51(3):191-6. PubMed ID: 17554481
    [Abstract] [Full Text] [Related]

  • 3. [Efficacy and safety of anti-tumor necrosis factor α monoclonal antibodies in 16 patients with severe/refractory vasculo Behcet's disease].
    Li L, Liu JJ, Yu X, Wu D, Zhang SZ, Yang YJ, Zhou JX, Zeng XF, Zhang FC, Zheng WJ.
    Zhonghua Nei Ke Za Zhi; 2020 Apr 01; 59(4):303-308. PubMed ID: 32209197
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behçet's disease.
    Abu El-Asrar AM, Abboud EB, Aldibhi H, Al-Arfaj A.
    Int Ophthalmol; 2005 Jun 01; 26(3):83-92. PubMed ID: 17031510
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.
    Ohno S, Nakamura S, Hori S, Shimakawa M, Kawashima H, Mochizuki M, Sugita S, Ueno S, Yoshizaki K, Inaba G.
    J Rheumatol; 2004 Jul 01; 31(7):1362-8. PubMed ID: 15229958
    [Abstract] [Full Text] [Related]

  • 10. Induction of ocular Behçet's disease remission after short-term treatment with infliximab: a case series of 11 patients with a follow-up from 4 to 16 years.
    Sfikakis PP, Arida A, Ladas DS, Markomichelakis N.
    Clin Exp Rheumatol; 2019 Jul 01; 37 Suppl 121(6):137-141. PubMed ID: 31856941
    [Abstract] [Full Text] [Related]

  • 11. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V, Blanco R, Beltrán E, Sánchez-Bursón J, Mesquida M, Adán A, Hernandez MV, Hernandez Garfella M, Valls Pascual E, Martínez-Costa L, Sellas-Fernández A, Cordero Coma M, Díaz-Llopis M, Gallego R, Salom D, García Serrano JL, Ortego N, Herreras JM, Fonollosa A, García-Aparicio AM, Maíz O, Blanco A, Torre I, Fernández-Espartero C, Jovani V, Peiteado-Lopez D, Pato E, Cruz J, Fernández-Cid C, Aurrecoechea E, García M, Caracuel MA, Montilla C, Atanes A, Hernandez FF, Insua S, González-Suárez S, Sánchez-Andrade A, Gamero F, Linares L, Romero-Bueno F, García AJ, Almodovar R, Minguez E, Carrasco Cubero C, Olive A, Vázquez J, Ruiz Moreno O, Jiménez-Zorzo F, Manero J, Muñoz Fernández S, Rueda-Gotor J, González-Gay MA.
    Rheumatology (Oxford); 2014 Dec 01; 53(12):2223-31. PubMed ID: 24996907
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effects and safety of infliximab administration in refractory uveoretinitis with Behçet's disease].
    Tanaka H, Sugita S, Yamada Y, Kawaguchi T, Iwanaga Y, Kamoi K, Yokota M, Takase H, Mochizuki M.
    Nippon Ganka Gakkai Zasshi; 2010 Feb 01; 114(2):87-95. PubMed ID: 20187505
    [Abstract] [Full Text] [Related]

  • 16. Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.
    Sugimura N, Mizoshita T, Sugiyama T, Togawa S, Miyaki T, Suzuki T, Tanida S, Kataoka H, Sasaki M.
    Dig Liver Dis; 2019 Jul 01; 51(7):967-971. PubMed ID: 30872086
    [Abstract] [Full Text] [Related]

  • 17. Behçet's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis.
    Adler S, Baumgartner I, Villiger PM.
    Arthritis Care Res (Hoboken); 2012 Apr 01; 64(4):607-11. PubMed ID: 22162223
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S, Graziani G, Marcolongo R.
    Ann N Y Acad Sci; 2007 Sep 01; 1110():474-84. PubMed ID: 17911463
    [Abstract] [Full Text] [Related]

  • 20. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, Steiner G, Smolen JS.
    Rheumatology (Oxford); 2009 Nov 01; 48(11):1451-4. PubMed ID: 19748965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.